REG - Feedback PLC - Director/PDMR Shareholding

FeedbackAnnouncement

Yesterday 15:45

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251223:nRSW7148Ma&default-theme=true

RNS Number : 7148M  Feedback PLC  23 December 2025

 

Feedback Plc

 

Director/PDMR shareholding

 

Feedback plc (AIM: FDBK, "Feedback" or the "Company"), the clinical
infrastructure specialist, announces that on 23 December 2025 the Company was
notified of the following Director and PDMR dealing(s) in the Company's
ordinary shares of 1 penny each ("Ordinary Shares"):

 

Tom Oakley, CEO, purchased 60,904 Ordinary Shares at a price of 8.19 pence per
Ordinary Share.

 

Emma Oswick (Stuart), (Non-Board) CFO, purchased 60,459 Ordinary Shares at a
price of 8.27 pence per Ordinary Share.

 

Details of the Ordinary Shares held are detailed in the table below:

 

 Director/ PDMR         Position         Existing interest in Ordinary Shares  Ordinary Shares purchased  Total beneficial interest in Ordinary Shares  Total interest in Company's issued share capital
 Tom Oakley             CEO              50,000                                60,904                     110,904                                       0.25%
                        (Non-Board) CFO  -                                     60,459                     60,459                                        0.14%

 Emma Oswick (Stuart)

 

 

The notification set out below is provided in accordance with the requirements
of the UK Market Abuse Regulation:

 

 1    Details of the person discharging managerial responsibilities / person closely

    associated

 a)   Names                                                        a)   Tom Oakley

                                                                   b)   Emma Oswick (Stuart)

 2    Reason for the notification

 a)   Position/status                                              a)   CEO

                                                                   b)   (Non-Board) CFO
 b)   Initial notification /Amendment                              Initial notification

 3    Details of the issuer, emission allowance market participant, auction

    platform, auctioneer or auction monitor

 a)   Name                                                         Feedback plc

 b)   LEI                                                          213800UGOF2GT2U2RV90

 4    Details of the transaction(s): section to be repeated for (i) each type of

    instrument; (ii) each type of transaction; (iii) each date; and (iv) each
      place where transactions have been conducted
 a)   Description of the financial instrument, type of instrument  Ordinary Shares of 1 penny each in Feedback plc

      Identification code                                          GB00BJN59X09

 b)   Nature of the transaction                                    Purchase of Ordinary Shares

                                                                   Purchase of Ordinary Shares
 c)   Price(s) and volume(s)

                                                                                     Price(s)          Volume(s)
                                                                                     a)   8.19         a)   60,904
                                                                                     b)   8.27         b)   60,459

 d)   Aggregated information

      - Aggregated volume                                          a)   £4,988.04

                                                                   b)   £4,999.96

      - Price

 e)   Date of the transaction                                      a)   23 December 2025

                                                                   b)   23 December 2025
 f)   Place of the transaction                                     London Stock Exchange, AIM Market (XLON)

 

 

 

--Ends--

Enquiries:

 

 Feedback plc                                +44 (0) 20 3997 7634

 Tom Oakley, CEO                             IR@fbk.com (mailto:IR@fbk.com)

 Emma Oswick, CFO

 Panmure Liberum Limited (NOMAD and Broker)  +44 (0)20 7886 2500

 Emma Earl/Mark Rogers (Corporate Finance)

 Rupert Dearden (Corporate Broking)

 Walbrook PR Ltd;                            Tel: 020 7933 8780 or feedbackplc@walbrookpr.com
                                             (mailto:feedbackplc@walbrookpr.com)
 Nick Rome/Joe Walker                        07748 325 236 or 07407 020 470

 

About Feedback plc

 

Feedback plc liberates the data and knowledge from multiple healthcare IT
systems and delivers better workflow to enable clinicians to communicate,
collaborate and provide the best healthcare for their patients. We connect
care settings with diagnostic and other relevant data to drive better, faster,
safer decision that improve outcomes for patients.

 

By linking different clinical systems together into a seamless view of the
patient, we can streamline patient pathways and deliver a digital health and
diagnostics record across multiple care providers.

 

Bleepa® is our communication and collaboration platform that displays
clinical results at a certified and regulated quality, which enables
multi-disciplinary team working and diagnostic-enhanced advice and guidance.
CareLocker® is our patient-facing platform that gives patients access and
control over their diagnostic and other clinical data.

 

The Company has a number of growth opportunities domestically and
internationally across a range of public and private healthcare markets
including the NHS. Our highly scalable software-as-a-service (SaaS) based
model is expected to provide increasing levels of revenue visibility as the
Company grows its customer base.

 

https://feedbackmedical.com/
(https://urldefense.proofpoint.com/v2/url?u=https-3A__feedbackmedical.com_&d=DwMGaQ&c=euGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM&r=lwwmT1lSfgELFLcwvlJQ2ZXDKcVbkQyitKwD17cChBQ&m=oBFM-ht-5vvdSXufzCuQmLfPWIaMcFGcjFY8Tl7Z-dsq0iW8FbXgExGw9gLP3va-&s=kayb21_5OhwDnHa1pJnJQjB1999VQgQynAFl7rWXro4&e=)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHPPGPWPUPAGAW



            Copyright 2019 Regulatory News Service, all rights reserved